Clinical Trials Directory

Trials / Completed

CompletedNCT06618677

Efficacy of a Low FODMAP Diet in IBS Children and Impact on Urinary and Faecal Metabolome

Efficacy of a Low FODMAP Diet in IBS Children and Impact on Microbiota, Urinary and Faecal Metabolome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
University of Bari · Academic / Other
Sex
All
Age
4 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain associated with defecation, or changes in stool frequency or stool form . The low FODMAPs diet (LFD) is a relatively new approach in the management of IBS and focuses on limiting intake of poorly absorbed carbohydrates. FODMAPs are highly fermentable but poorly absorbed short-chain carbohydrates and polyols contained in a wide variety of foods. FODMAPs include oligosaccharides (fructans, fructo-oligosaccharides = FOS and galacto-oligosaccharides = GOS), disaccharides (lactose), monosaccharides (fructose), and polyols (sorbitol, mannitol, maltitol, xylitol, polydextrose, and isomalt). Many studies and meta-analysis in adults have shown that a low FODMAPs diet is effective in reducing IBS symptoms, particularly bloating and abdominal pain. On the other hand, evidences in children are scarce. Previous studies in adults have demonstrated differences in urine metabolites between IBS patients receiving LFD compared to a high FODMAP diet (HFD), providing interesting hypotheses for pathophysiological mechanisms in IBS. Aim of this study is to evaluate the efficacy of a LFD on gastrointestinal symptoms in children with IBS. Moreover, the investigators will assess the impact of LFD vs a diet with a standard content of FODMAPs (SFD) on the fecal and urinary metabolomic profile of pediatric IBS patients. This is a single center, prospective, single blind low versus standard FODMAPs diet trial with crossover performed at Pediatric Gastroenterology Unit at the University of Bari. The trial includes four phases (run-in, low FODMAP diet, wash out and standard FODMAP diet). The run-in phase (weeks 1-2) aim to assess basal symptoms while on habitual diet and only symptomatic children (VAS\>3) will progress to the dietetic intervention trial. Then patients will be randomized to low or standard FODMAP diet for 14 days; then, children from both arms start the wash-out period of two weeks and subsequently start the final 2-week period on standard or low FODMAP diet.

Detailed description

Single center, prospective, single blind low versus standard FODMAPs diet trial with crossover performed at Pediatric Gastroenterology Unit at the University of Bari Metabolomic analysis will be performed at Department of Soil, Plant and Food Science, University of Bari Aldo Moro. The study will include all consecutive patients diagnosed with IBS according to the Rome IV criteria at Giovanni XXII Children's Hospital of Bari. The Giovanni XXII Children's Hospital of Bari is the tertiary referral center for the diagnosis and follow-up of gastrointestinal disorders in our region, covering an estimated population of 1400000 children, (National Institute of Statistics-https://www.istat.it accessed on 1 January 2023) with more than 10000 children followed up in the gastrointestinal clinic. The trial includes four phases (run-in, low FODMAP diet, wash out and standard FODMAP diet). The run-in phase (weeks 1-2) aim to assess basal symptoms while on habitual diet and only symptomatic children (VAS\>3) will progress to the dietetic intervention trial. Then patients will be randomized to low or standard FODMAP diet for 14 days; then, children from both arms start the wash-out period of two weeks and subsequently start the final 2-week period on standard or low FODMAP diet. The order of the dietetic regimens is established according a computer-generated randomization list. Fecal and urinary samples for analyzing metabolome will be collected before interventions and at the end of each dietetic regimen. The study adheres to the Declaration of Helsinki, was approved by the institutional ethical committee. All patients gave full written informed consent. Dietetic intervention An experienced dietician will design two different dietetic regimens (SFD and LFD), as a tailored personalized menu of 2 weeks duration, with manual calculation of nutrients and kilocalories according child age and weight. At enrollment the dietician will explain the diets in detail to the families who will be not aware of the content of FODMAP (low vs. standard). Parents will be only advised that the purpose of the study is to "Assess whether changing the amount of certain foods in the diet could affects symptoms of IBS" and the concept of FODMAPs wont be never mentioned during the study. Both menus will be normocaloric and balanced in macro- and micronutrients in relation to the age of the patient under study, according to the main principles of the Mediterranean diet. All menus comprise five meals during the day: breakfast, snack, lunch, snack and dinner. Food options present in the menus will be agree between the dietician, parents and children. The food intake will be recorded on a diary and the same dietician, during follow-up visits checked dietary compliance. A proper dietary adherence was defined if percentage of amount of food left was less than 10% and number of times non-compliant per week was less than 2.

Conditions

Interventions

TypeNameDescription
OTHERLOW FODMAPs Dietpatients will be randomized to low or standard FODMAP diet for 14 days; then, children from both arms started the wash-out period of two weeks and subsequently started the final 2-week period on standard or low FODMAP diet. The LFD will have a FODMAP content expressed in grams 0.15 g/kg/d FODMAPs (maximum 10 g/day) while the SFD will contain 0.7 g/kg/d FODMAPs (maximum 60 g/day).

Timeline

Start date
2023-01-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-10-01
Last updated
2026-02-09

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06618677. Inclusion in this directory is not an endorsement.